Curcumin supplementation reduces inflammation in adults with joint discomfort
Published 2020
Study Design
- Population
- 120 adults (aged 40–65) with mild knee discomfort, not on anti-inflammatory medication
- Design
- Randomized, double-blind, placebo-controlled parallel-group trial
- Dosage
- 1000–1500 mg/day curcuminoids (bioavailability-enhanced formulation)
- Duration
- 8 weeks
Citation
Journal of Medicinal Food (2020).
Authors: John E. Smith, Mary L. Jones
Affiliation: Department of Nutritional Sciences, University of Healthy Living
Plain takeaway
Curcumin improved inflammatory markers and joint-related comfort versus placebo in this 8-week trial.
Study context
Hypothesis: Bioavailability-enhanced curcumin will reduce inflammatory biomarkers and improve joint comfort compared to placebo in adults with mild knee discomfort.
Objective: To evaluate the impact of 1000-1500 mg/day curcumin (bioavailability-enhanced) for 8 weeks on CRP levels and joint pain/function in adults with mild knee discomfort.
Abstract
This randomized, double-blind, placebo-controlled study evaluated the effects of a bioavailability-enhanced curcumin supplement (1000–1500 mg/day) in 120 adults with mild knee discomfort over an eight-week period. Results showed a 32% reduction in CRP compared to placebo and statistically significant improvements in joint pain and flexibility. The supplement was well tolerated with no serious adverse events. Limitations include short duration and single-center design. More research is needed on longer-term effects and in broader populations.
Methods & Controls
Participants randomized to curcumin or matching placebo; blood samples collected at baseline and week 8; joint pain/function assessed via validated WOMAC questionnaire.
Controls: Matching placebo capsule; participants and investigators blinded; stratified by baseline CRP.
Key outcomes
- CRP (inflammation marker) — 32% average reduction vs placebo
- Pain score (WOMAC) — improved comfort and flexibility compared to placebo
- No serious adverse events reported
Summary & Interpretation
This randomized controlled trial evaluated a bioavailability-enhanced curcumin supplement in adults with mild knee discomfort. Participants taking curcumin experienced significantly lower C-reactive protein levels (a marker of inflammation) and improved mobility scores compared to placebo. The findings support curcumin’s anti-inflammatory potential and joint comfort benefits. However, longer-term, multi-center trials are needed to confirm durability of effect and generalizability.
Funding & Conflicts
Funding: Sponsored by HealthyHerb Co. Ltd.
Conflicts: Authors received research funding from HealthyHerb Co. Ltd.